Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Nicky Sunshine: On Laughter as Medicine

    ‘Don’t Take It For Granted’: As Young All-Stars Dazzle, Clayton Kershaw Get His Flowers

    Will Commanders WR Terry McLaurin Get the Contract His All-Pro Play Commands?

    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram Pinterest VKontakte
    Sg Latest NewsSg Latest News
    • Home
    • Politics
    • Business
    • Technology
    • Entertainment
    • Health
    • Sports
    Sg Latest NewsSg Latest News
    Home»Health»The Mount Sinai Hospital Announces Tender Pricing Information
    Health

    The Mount Sinai Hospital Announces Tender Pricing Information

    AdminBy AdminNo Comments6 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr Email
    Share
    Facebook Twitter LinkedIn Pinterest Email


    NEW YORK, July 16, 2025 /PRNewswire/ — The Mount Sinai Hospital (“MSH”) today announced tender pricing information.

    Pursuant to the Offer to Purchase dated July 1, 2025 (as it may be amended or supplemented, the “Offer to Purchase”), MSH invited Holders to tender, subject to the applicable Tender Cap, their Target Bonds for cash at a purchase price based on a fixed spread over the relevant Reference Yield equal to the bid-side yield of the relevant Reference U.S. Treasury Security, plus accrued and unpaid interest on such Target Bonds tendered for purchase from the last interest payment date up to, but not including, the Settlement Date, and on the terms and as further described in the Offer to Purchase. All capitalized terms used herein and not otherwise defined are used as defined in the Offer to Purchase.

    The Early Tender Deadline occurred at 5:00 p.m., New York City time, on July 15, 2025, and has not been extended. The Expiration Date is 5:00 p.m., New York City time, on July 30, 2025, and the Settlement Date is August 4, 2025.

    As set forth in the Offer to Purchase, the Tender Offers are subject to the Aggregate Minimum Tender Amount and the applicable Tender Caps. As of the Early Tender Date, the aggregate principal amount of tendered Target Bonds has exceeded the Aggregate Minimum Tender Amount and none of the Tender Caps have been exceeded. As a result, all Target Bonds tendered as of the Early Tender Date are expected to be fully accepted for purchase, without proration, by MSH subject to the terms of the Tender Offers. Any additional tender offers to be received after the Early Tender Date and on or before the Expiration Date remain subject to the applicable Tender Cap and therefore only those offers, if any, remain subject to proration as described in the Offer to Purchase.

    The Reference Yield and Total Consideration for Target Bonds tendered at or prior to the Early Tender Deadline and accepted for purchase by MSH was determined at 10:00 a.m., New York City time, on July 16, 2025 and are listed in the table set forth below. Subject to satisfaction of the conditions set forth in the Offer to Purchase, MSH intends to accept for purchase the aggregate principal amount of Target Bonds tendered in the Offer to Purchase set forth in the table below.

    The Settlement Date is the day on which MSH will provide payment of the Total Consideration or the Late Tender Consideration, as applicable, plus in each case Accrued Interest with respect to Target Bonds that are validly tendered prior to or at the Expiration Date and that are accepted for purchase. It is anticipated that the Settlement Date for the Tender Offers will be August 4, 2025, the third business day after the Expiration Date.

    CUSIP
    No.

    (Base
    623115)
    (1)

    Maturity
    Date
    (July 1)

    Principal
    Amount
    Outstanding

    Principal
    Amount
    Tendered

    Principal
    Amount
    Expected to
    be Accepted
    for Purchase

    Interest
    Rate

    Reference
    Yield
    (2)

    Fixed
    Spread

    Purchase
    Yield

    AC6

    2035

    $75,000,000

    $21,913,000

    $21,913,000

    3.831 %

    4.451 %

    +196 bps

    6.411 %

    AD4

    2048

    $307,000,000

    $48,567,000

    $48,567,000

    3.981 %

    4.982 %

    +187 bps

    6.852 %

    AE2

    2049

    $500,000,000

    $193,914,000

    $193,914,000

    3.737 %

    4.982 %

    +197 bps

    6.952 %

    AF9

    2050

    $400,000,000

    $77,459,000

    $77,459,000

    3.391 %

    4.987 %

    +192 bps

    6.907 %

    CUSIP
    No.

    (Base
    623115)
    (1)

    Principal
    Amount
    Outstanding

    Purchase
    Yield

    Offer
    Purchase
    Price*

    Early
    Tender
    Premium*

    Total
    Consideration**

    Late
    Tender
    Offer
    Consideration***

    AC6

    $75,000,000

    6.411 %

    $842.27

    $50.00

    $892.27

    $842.27

    AD4

    $307,000,000

    6.852 %

    $714.71

    $50.00

    $764.71

    $714.71

    AE2

    $500,000,000

    6.952 %

    $641.46

    $50.00

    $691.46

    $641.46

    AF9

    $400,000,000

    6.907 %

    $584.71

    $50.00

    $634.71

    $584.71

    *       Per $1,000 principal amount.
    **     Per $1,000 principal amount for offers received on or prior to the Early Tender Date.
    ***    Per $1,000 principal amount for offers received after the Early Tender Date and on or prior to the Expiration Date.

    As set forth in the Offer to Purchase, the Offer is subject to the satisfaction of certain conditions. See “THE OFFER— Conditions to the Offer” in the Offer to Purchase.

    (1) CUSIP is a registered trademark of the American Bankers Association (the “ABA”). CUSIP data herein is provided by CUSIP Global Services (“CGS”), managed on behalf of the American Bankers Association by FactSet Research Systems Inc. The CUSIP number listed above is being provided solely for convenience of reference and neither MSH, the Dealer Manager, the Information and Tender Agent, nor their respective agents or counsel make any representation with respect to such number or undertake any responsibility for its accuracy.
    (2) The Reference Yield is based on the Reference U.S. Treasury Security set forth in the Offer to Purchase.

    Information Relating to the Offer

    MSH commenced the Offers on July 1, 2025. Jefferies LLC is the Dealer Manager (the “Dealer Manager”) for the tender offer. Investors with questions regarding the Offers may contact Jefferies LLC at (212) 284-2300, (212) 708-2901 or [email protected]. Globic Advisors Inc. is the information and tender agent for the tender offer (the “Information and Tender Agent”) and can be contacted at (212) 227-9622, [email protected], or www.globic.com/mountsinai.

    The full details of the Offer are included in the Offer to Purchase. Holders are strongly encouraged to read carefully the Offer to Purchase, including materials incorporated by reference therein, because they will contain important information. The Offer to Purchase may be obtained from Globic Advisors Inc. through the means described in the preceding paragraph.

    About Mount Sinai Hospital

    Certain information relating to the Target Bonds and MSH may be obtained by contacting the Information and Tender Agent. Such information is limited to the Offer to Purchase and any information incorporated therein by reference.

    Forward-Looking Statements

    Statements included or incorporated by reference herein may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on expectations, forecasts and assumptions by MSH’s management and involve a number of risks, uncertainties and other factors that could cause actual results to differ materially from those stated, including, without limitation, the risks set forth in the offering document incorporated by reference into the Offer to Purchase. MSH cannot be certain that any expectations, forecasts or assumptions made by management in preparing these forward-looking statements will prove accurate, or that any projections will be realized. It is to be expected that there may be differences between projected and actual results. Any forward-looking statement speaks only as of the date on which it is made, and MSH assumes no obligation to update or revise such statement, whether as a result of new information, future events or otherwise, except as required by applicable law.

    SOURCE The Mount Sinai Hospital

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Admin
    • Website

    Related Posts

    Nicky Sunshine: On Laughter as Medicine

    Peanut Allergy Market Set to Grow at a 16% CAGR During the Study Period (2020-2034) Owing to Current Usage of Epinephrine, Anticipated Usage of XOLAIR in Adults, PALFORZIA in Toddlers and Expected Entry of Viaskin Peanut Patches

    Healthy babies born in Britain after scientists used DNA from three people to avoid genetic disease

    Modern Missiles, Lasting Fallout: Health and Social Costs

    Add A Comment
    Leave A Reply Cancel Reply

    Editors Picks

    Microsoft’s Singapore office neither confirms nor denies local layoffs following global job cuts announcement

    Google reveals “material 3 expressive” design – Research Snipers

    Trump’s fast-tracked deal for a copper mine heightens existential fight for Apache

    Top Reviews
    9.1

    Review: Mi 10 Mobile with Qualcomm Snapdragon 870 Mobile Platform

    By Admin
    8.9

    Comparison of Mobile Phone Providers: 4G Connectivity & Speed

    By Admin
    8.9

    Which LED Lights for Nail Salon Safe? Comparison of Major Brands

    By Admin
    Sg Latest News
    Facebook X (Twitter) Instagram Pinterest Vimeo YouTube
    • Get In Touch
    © 2025 SglatestNews. All rights reserved.

    Type above and press Enter to search. Press Esc to cancel.